Jennewein Biotechnology flags HMOs’ potential in inhibiting infectious diseases

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

22 Jun 2021 --- 108Labs is building a “Cellufacturing” facility for cell-based human milk, targeting a ton of milk production per day in the first stage. The US-based... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

22 Jun 2021 --- Throughout the global COVID-19 pandemic, NutritionInsight is dedicated to bringing its readers all the latest and most relevant industry updates. Visit this... Read More

FormattedPicture

FOOD RESEARCH

18 Jun 2021 --- Evolve BioSystems’ activated Bifidobacterium infantis EVC001 bacterial strain has been found to influence breastfed infants’ immune systems. This... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

16 Jun 2021 --- A new Kappa Bioscience-backed study has found low vitamin K status to be predictive of higher mortality for COVID-19. The latest findings suggest that vitamin K... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

16 Jun 2021 --- Probiotic supplier Probi and Swedish D2C cosmetics and wellness company Oriflame are partnering to globally launch a probiotic supplement targeting general gut... Read More

trans